8-78711382-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016010.3(ZC2HC1A):​c.705-3839A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.643 in 151,118 control chromosomes in the GnomAD database, including 33,074 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 33074 hom., cov: 29)

Consequence

ZC2HC1A
NM_016010.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.12

Publications

5 publications found
Variant links:
Genes affected
ZC2HC1A (HGNC:24277): (zinc finger C2HC-type containing 1A) Predicted to enable metal ion binding activity. [provided by Alliance of Genome Resources, Apr 2022]
IL7 (HGNC:6023): (interleukin 7) The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. IL7 plays an essential role in lymphoid cell survival, and in the maintenance of naive and memory T cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Jul 2020]
IL7 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • epidermodysplasia verruciformis, susceptibility to, 5
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.881 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZC2HC1ANM_016010.3 linkc.705-3839A>G intron_variant Intron 7 of 8 ENST00000263849.9 NP_057094.2
ZC2HC1ANM_001362969.2 linkc.705-608A>G intron_variant Intron 7 of 9 NP_001349898.1
ZC2HC1ANR_156423.2 linkn.765-608A>G intron_variant Intron 7 of 10
IL7XM_011517523.4 linkc.414+25092T>C intron_variant Intron 5 of 5 XP_011515825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZC2HC1AENST00000263849.9 linkc.705-3839A>G intron_variant Intron 7 of 8 1 NM_016010.3 ENSP00000263849.3

Frequencies

GnomAD3 genomes
AF:
0.644
AC:
97216
AN:
151000
Hom.:
33074
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.410
Gnomad AMI
AF:
0.771
Gnomad AMR
AF:
0.726
Gnomad ASJ
AF:
0.564
Gnomad EAS
AF:
0.903
Gnomad SAS
AF:
0.729
Gnomad FIN
AF:
0.735
Gnomad MID
AF:
0.541
Gnomad NFE
AF:
0.731
Gnomad OTH
AF:
0.627
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.643
AC:
97241
AN:
151118
Hom.:
33074
Cov.:
29
AF XY:
0.646
AC XY:
47646
AN XY:
73798
show subpopulations
African (AFR)
AF:
0.410
AC:
16917
AN:
41288
American (AMR)
AF:
0.726
AC:
11009
AN:
15160
Ashkenazi Jewish (ASJ)
AF:
0.564
AC:
1955
AN:
3466
East Asian (EAS)
AF:
0.903
AC:
4649
AN:
5148
South Asian (SAS)
AF:
0.730
AC:
3484
AN:
4774
European-Finnish (FIN)
AF:
0.735
AC:
7616
AN:
10358
Middle Eastern (MID)
AF:
0.541
AC:
159
AN:
294
European-Non Finnish (NFE)
AF:
0.731
AC:
49446
AN:
67634
Other (OTH)
AF:
0.625
AC:
1304
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1427
2853
4280
5706
7133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
784
1568
2352
3136
3920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.702
Hom.:
55776
Bravo
AF:
0.638
Asia WGS
AF:
0.753
AC:
2610
AN:
3470

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.44
DANN
Benign
0.45
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1483573; hg19: chr8-79623617; API